SBI MNC FUND
Direct Plan · IDCW · SBI Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +2.93% | +2.62% | 137 of 255 |
| 1M | -1.31% | +0.77% | 212 of 255 |
| 3M | -4.22% | -4.63% | 103 of 252 |
| 6M | +6.25% | +2.44% | 68 of 251 |
| YTD | +11.57% | +0.02% | 36 of 255 |
| 1Y | +10.22% | -0.51% | 35 of 232 |
| 2Y | +3.89% | +1.57% | 67 of 187 |
| 3Y | +6.95% | +11.99% | 117 of 142 |
| 5Y | +7.23% | +9.56% | 73 of 102 |
| 7Y | +12.44% | +14.11% | 56 of 84 |
| 10Y | +9.01% | +11.42% | 48 of 68 |
| INCEPTION | +12.00% | — | — |
Ranked among: Equity Scheme - Sectoral/ Thematic.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +3.43% | +26.32% | -23.48% | 65% | 26% |
| 6M | +6.93% | +49.69% | -23.54% | 67% | 27% |
| 1Y | +14.55% | +86.17% | -18.67% | 75% | 32% |
| 2Y | +12.75% | +53.17% | -9.03% | 85% | 37% |
| 3Y | +11.56% | +31.05% | -3.93% | 93% | 40% |
| 5Y | +11.35% | +20.97% | -4.38% | 98% | 43% |
| 7Y | +11.29% | +15.76% | +5.78% | 100% | 44% |
| 10Y | +11.12% | +16.49% | +6.82% | 100% | 44% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity96.26%
- Debt0.31%
- Cash3.43%
- Other0.00%
Market Cap Split
- Large Cap39.41%
- Mid Cap24.91%
- Small Cap31.94%
- Others3.74%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 35.59 | 28.09 |
| P/B | 6.39 | 4.63 |
| Price / Sales | 5.09 | 3.31 |
| Price / Cash Flow | 24.94 | 21.08 |
| Dividend Yield (%) | 1.02 | 1.16 |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| Divis Laboratories | Pharmaceuticals & Biotechnology | 5.82% | +0.18% |
| Cummins | Industrial Products | 4.77% | +0.21% |
| Bosch | Auto Components | 4.13% | +0.11% |
| Sona BLW Precision Forgings | Auto Components | 3.90% | +0.27% |
| Vedanta Aluminium Metal | Non - Ferrous Metals | 3.88% | -0.01% |
| Navin Fluorine International | Chemicals & Petrochemicals | 3.62% | +0.00% |
| Sun Pharmaceutical | Pharmaceuticals & Biotechnology | 3.42% | -0.13% |
| TREPS | Reverse Repo / TREPS | 3.35% | — |
| Aether Industries | Chemicals & Petrochemicals | 3.20% | -0.12% |
| ABB | Electrical Equipment | 3.19% | +0.01% |
| Anthem Biosciences | Pharmaceuticals & Biotechnology | 2.96% | -0.12% |
| Siemens | Electrical Equipment | 2.92% | -0.08% |
| Hyundai Motor India | Automobiles | 2.67% | -0.09% |
| Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.62% | -0.44% |
| Biocon | Pharmaceuticals & Biotechnology | 2.61% | -0.15% |
View all 48 holdings
| Samvardhana Motherson International | Auto Components | 2.56% | +0.02% |
| Grindwell Norton | Industrial Products | 2.50% | +0.05% |
| Amagi Media Labs | IT - Services | 2.19% | +0.04% |
| Tenneco Clean Air | Auto Components | 2.18% | +0.03% |
| Cipla | Pharmaceuticals & Biotechnology | 2.11% | +0.01% |
| Vedanta | Diversified Metals | 2.03% | -0.04% |
| CCL Products | Agricultural Food & other Products | 2.00% | -0.03% |
| Kennametal | Industrial Manufacturing | 1.94% | -0.02% |
| Garware Technical Fibres | Textiles & Apparels | 1.93% | -0.01% |
| Britannia Industries | Food Products | 1.89% | -0.06% |
| Maruti Suzuki | Automobiles | 1.88% | -0.54% |
| Bharat Forge | Auto Components | 1.81% | -0.07% |
| Aster DM Quality Care | Equity | 1.75% | -0.05% |
| Foseco | Chemicals & Petrochemicals | 1.72% | +0.10% |
| Balkrishna Industries | Auto Components | 1.66% | +0.22% |
| Hindustan Unilever | Diversified FMCG | 1.65% | +0.01% |
| Cohance Lifesciences | Pharmaceuticals & Biotechnology | 1.53% | +0.04% |
| Gokaldas Exports | Textiles & Apparels | 1.51% | -0.12% |
| Poly Medicure | Equity | 1.47% | +0.00% |
| Coforge | IT - Software | 1.37% | -0.70% |
| ZF Commercial | Auto Components | 1.32% | -0.19% |
| Sudeep Pharma | Chemicals & Petrochemicals | 1.30% | +0.06% |
| Aequs | Aerospace & Defense | 1.19% | +0.46% |
| Timken | Industrial Products | 1.18% | +0.05% |
| Fortis Healthcare | Equity | 1.09% | -0.13% |
| Privi Speciality Chemicals | Chemicals & Petrochemicals | 0.90% | -0.03% |
| Indo-MIM | Industrial Manufacturing | 0.80% | +0.26% |
| Nestle | Food Products | 0.62% | -0.05% |
| 364T191126 | Money Market | 0.31% | +0.02% |
| Clean Science & Technology | Chemicals & Petrochemicals | 0.26% | -0.11% |
| Abbott | Pharmaceuticals & Biotechnology | 0.21% | -0.17% |
| Net Receivable / Payable | Net Current Assets | 0.08% | — |
| Margin amount for Derivative positions | Net Current Assets | 0.00% | — |
Sector Allocation · Sep 2026
View all 18 sectors
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 14.12 | 16.27 | Low Volatility |
| 3Y | 12.02 | 16.10 | Low Volatility |
| 5Y | 12.09 | 15.66 | Low Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.22 | -0.33 | Above Average |
| 3Y | 0.12 | -0.46 | Above Average |
| 5Y | 0.15 | 0.28 | Below Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.85% (published 2026-10-27).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 1.10 | 0.05 | Above Average |
| 3Y | 0.88 | 1.11 | Below Average |
| 5Y | 0.91 | 0.94 | Below Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Nippon India Taiwan Equity Fund
Regular Plan · IDCW option
|
+59.16% | +48.17% | — | +23.57% |
|
HDFC Pharma and Healthcare Fund
Direct Plan · IDCW Option
|
+23.60% | +30.61% | — | +29.76% |
|
Kotak Healthcare Fund
Regular Plan · IDCW Option
|
+21.84% | — | — | +19.69% |
|
ICICI Prudential US Bluechip Equity Fund
Regular Plan · IDCW
|
+20.06% | +19.12% | +12.26% | +15.80% |
|
SBI Automotive Opportunities Fund
Direct Plan · IDCW
|
+19.95% | — | — | +10.69% |
|
Nippon India Japan Equity Fund
Regular Plan · Bonus Option
|
+19.94% | +20.37% | +8.45% | +8.55% |
|
Mirae Asset Healthcare Fund
Direct Plan · Growth
|
+19.10% | +23.89% | +16.63% | +21.84% |
|
PGIM India Healthcare Fund
Direct Plan · Direct IDCW
|
+18.27% | — | — | +11.09% |
|
WhiteOak Capital Pharma and Healthcare Fund
Regular Plan · Growth Option
|
+17.09% | — | — | +20.29% |
|
quant Healthcare Fund
Direct Plan · Growth Option
|
+17.00% | +21.16% | — | +21.00% |
More From SBI Funds Management Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
SBI Automotive Opportunities Fund
Direct Plan · IDCW
|
+19.95% | — | — | +10.69% |
|
SBI Silver ETF
Regular Plan · Growth
|
+17.82% | — | — | +31.22% |
|
SBI HEALTHCARE OPPORTUNITIES FUND
Direct Plan · Growth
|
+17.68% | +24.49% | +19.13% | +17.96% |
|
SBI Silver ETF Fund of Fund
Direct Plan · Growth
|
+17.50% | — | — | +31.50% |
|
SBI Gold ETF
Regular Plan · Growth
|
+13.12% | +29.42% | +22.46% | +12.52% |
|
SBI US Specific Equity Active FoF
Direct Plan · IDCW
|
+12.78% | +25.79% | +15.21% | +17.11% |
|
SBI GOLD FUND
Direct Plan · IDCW
|
+12.69% | +29.55% | +22.51% | +10.27% |
|
SBI Children's Fund - Investment Plan
Direct Plan · Growth
|
+7.83% | +20.37% | +17.44% | +30.82% |
|
SBI CREDIT RISK FUND
Direct Plan · IDCW
|
+7.35% | +8.38% | +7.66% | +5.55% |
|
SBI CHILDREN'S FUND - SAVINGS PLAN
Direct Plan · Growth
|
+7.35% | +10.84% | +9.99% | +11.82% |
About This Scheme
Investment Objective
The Objective of the Scheme is to provide investors with maximum growth opportunity.
Stated Asset Allocation
Equity and equity related companies within MNC space including derivatives and foreign securities# 80%-100% High Other equities and equity related instruments 0%-20% High Units issued by REIT/InVIT^ 0%-10% Medium to High Debt instruments (including securitized debt) 0%-20% Medium Money market instruments 0%-20% Low
Fund Managers
Mr. Tanmaya Desai 01-Apr-2024
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch